Oberland Biotech operates internationally in the food, nutrition, and biotechnology sectors, trading, selling, and exporting nutritional supplements and food products. The company also engages in strategic collaborations, establishes subsidiaries and branches globally, and participates in projects across food and biotechnology. Leadership has emphasized scaling the product pipeline and building scalable operations. Oberland Biotech plans to strengthen its presence particularly in the United States and Asian markets. The company received CHF 2.5 million in seed funding to support product development, international expansion, recruitment, and marketing and sales growth. Phillip Josef Jancer is CEO and Founder.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

May 2026